CONFIRM 2 Registry

Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry (CONFIRM2)

Objective

The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.

Eligibility

  • Age >18 years
  • Undergoing clinically indicated CCTA with >64-detector row CT
  • Signed informed consent, including of release of medical information, long term follow-up and Health Insurance Portability and Accountability Act (HIPAA) documentation

NCT ID

NCT04279496

Want to learn more? Visit ClinicalTrials.gov.

Principal Investigator(s)
Status
Open and enrolling
Start Date